Jason N. Gorevic - Jun 2, 2020 Form 4/A - Amendment Insider Report for Teladoc Health, Inc. (TDOC)

Role: Chief Executive Officer, Director
Signature: /s/ Adam C. Vandervoort, attorney-in-fact
Stock symbol: TDOC
Transactions as of: Jun 2, 2020
Transactions value $: -$4,160,311
Form type: 4/A - Amendment
Date filed: 5/10/2021, 04:29 PM
Date Of Original Report: Jun 5, 2020
Next filing: Jun 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise	$38.5K	+23.1K	+3.44%	$1.67^*	694K	Jun 2, 2020	Direct	F1, F2
transaction	TDOC	Common Stock	Options Exercise	$11.6K	+1.93K	+0.28%	$6.01^*	696K	Jun 2, 2020	Direct	F1, F2
transaction	TDOC	Common Stock	Sale	-$265K	-1.6K	-0.23%	$165.60	695K	Jun 2, 2020	Direct	F1, F2, F3
transaction	TDOC	Common Stock	Sale	-$650K	-3.9K	-0.56%	$166.73	691K	Jun 2, 2020	Direct	F1, F2, F4
transaction	TDOC	Common Stock	Sale	-$824K	-4.92K	-0.71%	$167.70	686K	Jun 2, 2020	Direct	F1, F2, F5
transaction	TDOC	Common Stock	Sale	-$977K	-5.79K	-0.84%	$168.80	680K	Jun 2, 2020	Direct	F1, F2, F6
transaction	TDOC	Common Stock	Sale	-$1.32M	-7.79K	-1.15%	$169.66	672K	Jun 2, 2020	Direct	F1, F2, F7
transaction	TDOC	Common Stock	Sale	-$102K	-600	-0.09%	$170.41	672K	Jun 2, 2020	Direct	F1, F2, F8
transaction	TDOC	Common Stock	Sale	-$17.1K	-100	-0.01%	$171.32	672K	Jun 2, 2020	Direct	F1, F2
transaction	TDOC	Common Stock	Sale	-$51.8K	-300	-0.04%	$172.58	671K	Jun 2, 2020	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Employee Stock Option (right to buy)	Options Exercise	$0	-23.1K	-100%	$0.00^*	0	Jun 2, 2020	Common Stock	23.1K	$1.67	Direct	F1, F2, F9
transaction	TDOC	Employee Stock Option (right to buy)	Options Exercise	$0	-1.93K	-1.58%	$0.00	120K	Jun 2, 2020	Common Stock	1.93K	$6.01	Direct	F1, F2, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020.
F2	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020.
F3	Represents the weighted average price of transactions ranging from $165.23 to $166.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 8 to this Form 4.
F4	Represents the weighted average price of transactions ranging from $166.24 to $167.11, inclusive.
F5	Represents the weighted average price of transactions ranging from $167.25 to $168.24, inclusive.
F6	Represents the weighted average price of transactions ranging from $168.27 to $169.26, inclusive.
F7	Represents the weighted average price of transactions ranging from $169.28 to $170.27, inclusive.
F8	Represents the weighted average price of transactions ranging from $170.31 to $170.51, inclusive.
F9	The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 substantially equal monthly installments thereafter.
F10	The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested in 36 substantially equal monthly installments thereafter.

Remarks:

Note: This Form 4 amendment is being filed to amend the previous Form 4 filed on June 5, 2020 to include the Deemed Execution Date of June 3, 2020, which was previously omitted.